A Multicenter, randomized, active-controlled, double-blind, double-dummy, parallel group clinical trial, investigating the efficacy, safety and tolerability of continuous subcutaneous ND0612 infusion in comparison to oral IR-LD/CD in subjects with Pa

Administered By

Awarded By

Contributors

Start/End

  • November 20, 2019 - December 31, 2022